This announcement is a separate document:
康辰药业监事会关于公司2023年限制性股票激励计划预留授予激励对象名单的公示情况说明及核查意见
Beijing Konruns Pharmaceutical's Supervisory Board's statement on the publicity and verification of the reserved list of incentive objects for the restricted stock incentive plan for the company in 2023.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.